Latimeria chalumnae      TK      Eph

※ Eph family introduction

    Eph receptor tyrosine kinases are known able to bind their ephrin ligands and act as key regulator of cell contact-dependent signaling and patterning. Eph kinase contains fourteen members which can further be classified into two subclasses A and B in human. EphA1-8 and Eph10 belong to subclass A, EphB1-4 and EphB6 belong to subclass B. Eph kinases consist of two regions: intracellular region and extracellular region. The extracellular part contains a globular ligand-binding domain, a cysteine-rich region and two fibronectin type III repeats. The intracellular part contains a short juxtamembrane region, a kinase catalytic domain, a sterile α motif (SAM) protein−protein interaction domain and a PDZ-binding motif. Eph/ephrin binding will lead to very diverse biological readouts including adhesion versus repulsion and increased versus decreased motility. Depending on the different cell type and context, the interaction will lead to different downstream signaling pathway. In addition, evidence shows that endocytosis of Eph/ephrin and associated tissue-specific effectors are essential for diverse biological roles and processes (1).

Reference
1. Pitulescu, M.E. and Adams, R.H. (2010) Eph/ephrin molecules--a hub for signaling and endocytosis. Genes Dev, 24, 2480-2492. PMID: 21078817


There are 15 genes.  Reviewed (0 or Unreviewed (15

No.StatusEKPD IDGene IDGene Name
1
EKS-LAC-00005
ENSLACG00000014040
EPHB3
2
EKS-LAC-00002
ENSLACG00000006691
EPHA4
3
EKS-LAC-00001
ENSLACG00000006618
EPHA3
4
EKS-LAC-00006
ENSLACG00000013678
5
EKS-LAC-00004
ENSLACG00000003129
EPHA7
6
EKS-LAC-00014
ENSLACG00000002978
EPHB4
7
EKS-LAC-00008
ENSLACG00000011594
EPHA8
8
EKS-LAC-00010
ENSLACG00000011703
EPHA2
9
EKS-LAC-00003
ENSLACG00000004881
EPHB2
10
EKS-LAC-00011
ENSLACG00000009983
EPHA10
11
EKS-LAC-00013
ENSLACG00000016054
EPHB1
12
EKS-LAC-00007
ENSLACG00000012783
EPHA5
13
EKS-LAC-00012
ENSLACG00000001060
EPHA6
14
EKS-LAC-00009
ENSLACG00000005719
EPHB6
15
EKS-LAC-00015
ENSLACG00000013051
EPHA1